INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Most active filers · 30d

  1. 01FWFogarty Patrick W0B / 206S206 trades$1.10M
  2. 02Kurtz George0B / 202S202 trades$48.06M
  3. 03SPSaba Capital Management, L.P.67B / 19S · 11 late86 trades$21.51M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09SISarowitz Steven I2B / 34S36 trades$21.18M
  10. 10SLSpeiser Michael L0B / 35S35 trades$14.00M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 189 insiders$1.02M
  3. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  4. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  5. SELLMGNIMAGNITE, INC.Nov 5 – Nov 178 insiders$2.77M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

73,431 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
25.0K sh
Dec 2, 2025Dec 4, 2025
Page 1692 of 1836
← PrevNext →
traded Dec 2, 2025
+2d
SEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
25.0K sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
1,000 sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
1,000 sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
1,000 sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC Form 4

Evidence

0
RM
Rizik MatthewDirector
RKTRocket Companies, Inc.
Open-market sale · 10b5-1 plan
SELL$50K
2,500 sh
Dec 3, 2025Dec 4, 2025
traded Dec 3, 2025
+1dSEC Form 4

Evidence

0
CR
Chambers RebeccaChief Financial Officer
VCYTVERACYTE, INC.
Tax withholding · 10b5-1 plan
F$156K
3,384 sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC Form 4

Evidence

59
SC
Smith Christopher CharlesDirector
PARKPark Dental Partners, Inc.
Open-market purchase
BUY$100K
7,692 sh
Dec 3, 2025Dec 3, 2025
traded Dec 3, 2025
+0dSEC Form 4

Evidence

52
SI
Smith Philip IrvingDirector
PARKPark Dental Partners, Inc.
Open-market purchase
BUY$9,997
769 sh
Dec 3, 2025Dec 3, 2025
traded Dec 3, 2025
+0dSEC Form 4

Evidence

51
GC
Gerlach Todd ChristopherDirector
PARKPark Dental Partners, Inc.
Open-market purchase
BUY$100K
7,692 sh
Dec 3, 2025Dec 3, 2025
traded Dec 3, 2025
+0dSEC Form 4

Evidence

44
SG
Swenson Peter GDirector, CEO and Chairman
PARKPark Dental Partners, Inc.
Open-market purchase
BUY$50K
3,846 sh
Dec 3, 2025Dec 3, 2025
traded Dec 3, 2025
+0dSEC Form 4

Evidence

44
LS
Law Alan SiemsDirector
PARKPark Dental Partners, Inc.
Open-market purchase
BUY$25K
1,923 sh
Dec 3, 2025Dec 3, 2025
traded Dec 3, 2025
+0dSEC Form 4

Evidence

44
BJ
Bernander Christopher JamesDirector, Chief Financial Officer
PARKPark Dental Partners, Inc.
Open-market purchase
BUY$25K
1,923 sh
Dec 3, 2025Dec 3, 2025
traded Dec 3, 2025
+0dSEC Form 4

Evidence

42
OM
Otworth MichaelDirector, Executive Chairman
INVInnventure, Inc.
Open-market purchase
BUY$61K
12.0K sh
Dec 2, 2025Dec 3, 2025
traded Dec 2, 2025
+1dSEC Form 4

Evidence

39
AR
Austrup RolandChief Growth Officer
INVInnventure, Inc.
Open-market purchase
BUY$25K
4,900 sh
Dec 1, 2025Dec 3, 2025
traded Dec 1, 2025
+2dSEC Form 4

Evidence

38
RK
Rasmussen KrisChief Technology Officer
FIGFigma, Inc.
Open-market sale
SELL$646K
18.2K sh
Dec 1, 2025Dec 3, 2025
traded Dec 1, 2025
+2dSEC Form 4

Evidence

38
HA
Hardy AndrewChief Sales Officer
NXPINXP Semiconductors N.V.
Tax withholding
F$317K
1,736 sh
Apr 30, 2025Dec 3, 2025
traded Apr 30, 2025
+217dSEC Form 4

Evidence

38
DB
Delco Albert BradEVP & CFO
JBHTHUNT J B TRANSPORT SERVICES INC
Open-market sale
SELL$180K
1,000 sh
Dec 2, 2025Dec 3, 2025
traded Dec 2, 2025
+1dSEC Form 4

Evidence

36
TR
Trout Harry R. IIISee Remarks
ENTAENANTA PHARMACEUTICALS INC
Open-market sale
SELL$5,305
380 sh
Dec 2, 2025Dec 3, 2025
traded Dec 2, 2025
+1dSEC Form 4

Evidence

36
CS
Capps Kathleen S.See Remarks
ENTAENANTA PHARMACEUTICALS INC
Open-market sale
SELL$2,890
207 sh
Dec 2, 2025Dec 3, 2025
traded Dec 2, 2025
+1dSEC Form 4

Evidence

36
HA
Hardy AndrewChief Sales Officer
NXPINXP Semiconductors N.V.
Option exercise
M—
4,879 sh
Apr 30, 2025Dec 3, 2025
traded Apr 30, 2025
+217dSEC Form 4

Evidence

36
RB
Read BrianChief Financial Officer
SERVServe Robotics Inc. /DE/
Open-market sale
SELL$20K
2,057 sh
Dec 2, 2025Dec 3, 2025
traded Dec 2, 2025
+1dSEC Form 4

Evidence

35
HT
Herb TylerChief Accounting Officer
FIGFigma, Inc.
Open-market sale
SELL$109K
3,073 sh
Dec 1, 2025Dec 3, 2025
traded Dec 1, 2025
+2dSEC Form 4

Evidence

35
MB
Mulligan BrendanGeneral Counsel and Secretary
FIGFigma, Inc.
Open-market sale
SELL$331K
9,343 sh
Dec 1, 2025Dec 3, 2025
traded Dec 1, 2025
+2dSEC Form 4

Evidence

35
BK
Bliss KellyPresident, U.S. Group Health
TDOCTeladoc Health, Inc.
Open-market sale
SELL$34K
4,582 sh
Dec 2, 2025Dec 3, 2025
traded Dec 2, 2025
+1dSEC Form 4

Evidence

35
NC
Nueno CarlosPresident, International
TDOCTeladoc Health, Inc.
Open-market sale
SELL$29K
3,897 sh
Dec 2, 2025Dec 3, 2025
traded Dec 2, 2025
+1dSEC Form 4

Evidence

35
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Open-market sale
SELL$42K
1,416 sh
Dec 2, 2025Dec 3, 2025
traded Dec 2, 2025
+1dSEC Form 4

Evidence

35
MP
Melwani PraveerCFO and Treasurer
FIGFigma, Inc.
Open-market sale
SELL$559K
15.8K sh
Dec 1, 2025Dec 3, 2025
traded Dec 1, 2025
+2dSEC Form 4

Evidence

34
SM
Small MartinCFO & Senior Managing Director
BLKBlackRock, Inc.
Open-market sale
SELL$1.31M
1,258 sh
Dec 1, 2025Dec 3, 2025
traded Dec 1, 2025
+2dSEC Form 4

Evidence

32
VS
Voskanian ShauntChief Revenue Officer
FIGFigma, Inc.
Open-market sale
SELL$215K
6,076 sh
Dec 1, 2025Dec 3, 2025
traded Dec 1, 2025
+2dSEC Form 4

Evidence

31
IV
Ingram VanSVP, CHF DEVELOPMENT OFFICER
JACKJACK IN THE BOX INC
Open-market sale
SELL$2,805
147 sh
Dec 3, 2025Dec 3, 2025
traded Dec 3, 2025
+0dSEC Form 4

Evidence

31
CG
Canup Edward GCHIEF BANKING OFFICER
CBANCOLONY BANKCORP INC
Open-market purchase
BUY$8,475
500 sh
Nov 28, 2025Dec 3, 2025
traded Nov 28, 2025
+5dSEC Form 4

Evidence

31
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Open-market sale
SELL$26K
868 sh
Dec 2, 2025Dec 3, 2025
traded Dec 2, 2025
+1dSEC Form 4

Evidence

31
IV
Ingram VanSVP, CHF DEVELOPMENT OFFICER
JACKJACK IN THE BOX INC
Open-market sale
SELL$3,893
204 sh
Dec 3, 2025Dec 3, 2025
traded Dec 3, 2025
+0dSEC Form 4

Evidence

31
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Open-market sale
SELL$43K
1,394 sh
Dec 3, 2025Dec 3, 2025
traded Dec 3, 2025
+0dSEC Form 4

Evidence

30
PT
Pinner Jeffrey TsviChief Technology Officer
HOODRobinhood Markets, Inc.
Tax withholding
F$3.51M
27.3K sh
Dec 1, 2025Dec 3, 2025
traded Dec 1, 2025
+2dSEC Form 4

Evidence

30
BL
Berkley Neil LindsayChief Bus Ofcr & Interim CFO
ALECAlector, Inc.
Open-market sale
SELL$42K
37.3K sh
Dec 3, 2025Dec 3, 2025
traded Dec 3, 2025
+0dSEC Form 4

Evidence

30
WG
Wong-Sarad GracePrincipal Accounting Officer
ALECAlector, Inc.
Open-market sale
SELL$9,019
8,056 sh
Dec 3, 2025Dec 3, 2025
traded Dec 3, 2025
+0dSEC Form 4

Evidence

29
KC
Kleinerman ChristianEVP, Product Management
SNOWSnowflake Inc.
Open-market sale · 10b5-1 plan
SELL$2.50M
10.0K sh
Dec 1, 2025Dec 3, 2025
traded Dec 1, 2025
+2dSEC Form 4

Evidence

27
FW
Flint Christopher WadeEVP, President, Kemper Life
KMPRKEMPER Corp
Grant or award
A$500K
12.3K sh
Dec 1, 2025Dec 3, 2025
traded Dec 1, 2025
+2dSEC Form 4

Evidence